Reply to a letter from Ozgur Tanriverdi and Derya Kaskari regarding “Frequency of fibromyalgia syndrome in breast cancer patients”

Gaillard S, Stearns V (2011) Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management. Breast Cancer Res 13:205–211PubMedCentralPubMedCrossRefGoogle Scholar

Warner E, Keshavjee al-N, Shupak R et al (1997) Rheumatic symptoms following adjuvant therapy for breast cancer. Am J Clin Oncol 20(3):322–326PubMedCrossRefGoogle Scholar

Weir PT, Harlan GA, Nkoy FL et al (2006) The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes. J Clin Rheumatol 12(3):124–128PubMedCrossRefGoogle Scholar

Wolfe F, Clauw DJ, Fitzcharles MA et al (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 62:600–610CrossRefGoogle Scholar

Wolfe F, Smythe HA, Yunus MB et al (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172PubMedCrossRefGoogle Scholar

White KP, Speechley M, Harth M et al (1999) The London fibromyalgia study: the prevalence of fibromyalgia syndrome in London, Ontorio. J Rheumatol 26:1570–1576PubMedGoogle Scholar

Carmona L, Ballina J, Gabriel R et al (2001) The burden of musculoskeletal diseases in the general population in Spain: results of a national survey. Ann Rheum Dis 2001:1040–1045CrossRefGoogle Scholar

Hauser W, Schmutzer G, Glaesmer H et al (2009) Prevalence and predictors of pain in several body regions: results of a representative German population survey. Schmery 2009(23):461–470CrossRefGoogle Scholar

Akkaya N, Simsir-Atalay N, Taflan-Selcuk S et al (2012) Frequency of fibromyalgia syndrome in breast cancer patients. Int J Clin Oncol [Epub ahead of print]Google Scholar